SAN ANTONIO, TX (November 24, 2014) — This week on World Prematurity Day, the March of Dimes Foundation and the Perelman School of Medicine at the University of Pennsylvania celebrated the establishment of the March of Dimes Prematurity Research Center at the university. Over the next five years, the March of Dimes has committed to invest $10 million to create the new transdisciplinary center designed to accelerate research aimed at discovering the causes of preterm birth and new strategies to prevent it.
RALEIGH, NC (October 28, 2013) – DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to therapy and manage side effects arising from cancer treatment, today announced the signing of an agreement with Alamo Pharma Services, a subsidiary of Mission Pharmacal, for a twenty (20) person national sales team in the U.S. oncology market.
SAN ANTONIO, TX (August 21, 2013) – Urocit®-K (extended release potassium citrate), the proven urological treatment that blazed a trail into space to help NASA astronauts combat kidney stones, has begun a new journey here on Earth.
With the Urocit-K flagship leading the way, Mission Pharmacal Company has launched a new sales force to better deliver its entire fleet of urology medicines into the hands of physicians nationwide.